Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

The Pleasant Twp. Fire Department's former assistant chief of EMS operations was sentenced to 12 months in prison for two drug theft incidents that occurred when he worked at the Madison County ...

Americans consume more illicit drugs per capita than anyone else in the world; about 6% of the U.S. population uses them ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The US has been witnessing what many have called an “opioid epidemic” in recent years. Why has the US govt blamed China and ...

US President Donald Trump yesterday ordered 25% tariffs on Canadian and Mexican imports – lumping a 10% tax rate on goods from China as well saying Beijing needed to stanch the flow of fentanyl, a ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...